TWO SIGMA INVESTMENTS, LP
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1179392
NEW YORK, NY
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,089,129
+$2,975,098 QoQ
Shares Held
153,459
+1039.9% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 182 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 99.41352413348191.ToString("F0")%
Shared 0.ToString("F0")%
None 0.5864758665180928.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. KALV ranks #133 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in KALV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,089,129 | 153,459 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $114,031 | 13,463 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $312,081 | 26,950 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $332,160 | 28,197 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,273,550 | 191,699 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,030,547 | 165,759 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $999,536 | 103,794 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $892,458 | 99,162 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $427,308 | 54,365 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $117,732 | 17,416 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $368,537 | 37,453 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $1,291,142 | 97,592 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,140,120 | 122,643 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,362,796 | 56,878 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,072,489 | 80,673 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $539,240 | 28,396 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $329,870 | 27,262 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||